Literature DB >> 23511306

Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims.

Russell J Lewis1, Mike K Angier, Kelly S Williamson, Robert D Johnson.   

Abstract

Sertraline (Zoloft) is a selective serotonin reuptake inhibitor that is a commonly prescribed drug for the treatment of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, premenstrual dysphoric disorder and post-traumatic stress disorder. Although the use of sertraline is relatively safe, certain side effects may negatively affect a pilot's performance and become a factor in an aviation accident. The authors' laboratory investigated the distribution of sertraline and its primary metabolite, desmethylsertraline, in various postmortem tissues and fluids obtained from 11 fatal aviation accident cases between 2001 and 2004. Eleven specimen types were analyzed for each case, including blood, urine, vitreous humor, liver, lung, kidney, spleen, muscle, brain, heart and bile. Human specimens were processed utilizing solid-phase extraction, followed by characterization and quantitation employing gas chromatography-mass spectrometry. Whole blood sertraline concentrations obtained from these 11 cases ranged from 0.005 to 0.392 µg/mL. The distribution coefficients of sertraline, expressed as specimen/blood ratio, were as follows: urine, 0.47 ± 0.39 (n = 6); vitreous humor, 0.02 ± 0.01 (n = 4); liver, 74 ± 59 (n = 11); lung, 67 ± 45 (n = 11); kidney, 7.4 ± 5 (n = 11); spleen, 46 ± 45 (n = 10); muscle, 2.1 ± 1.3 (n = 8); brain, 22 ± 14 (n = 10); heart, 9 ± 7 (n = 11); and bile, 36 ± 26 (n = 8). Postmortem distribution coefficients obtained for sertraline had coefficients of variation ranging from 47-99%. This study suggests that sertraline likely undergoes significant postmortem redistribution.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23511306     DOI: 10.1093/jat/bkt014

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Cryptococcal Meningitis: Diagnosis and Management Update.

Authors:  Mahsa Abassi; David R Boulware; Joshua Rhein
Journal:  Curr Trop Med Rep       Date:  2015-06-01

Review 2.  Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.

Authors:  Sarah Lofgren; Mahsa Abassi; Joshua Rhein; David R Boulware
Journal:  Expert Rev Anti Infect Ther       Date:  2017-02-09       Impact factor: 5.091

3.  Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.

Authors:  Ali A Alhadab; Joshua Rhein; Lillian Tugume; Abdu Musubire; Darlisha A Williams; Mahsa Abassi; Melanie R Nicol; David B Meya; David R Boulware; Richard C Brundage
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-10-04       Impact factor: 2.745

4.  Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.

Authors:  Joshua Rhein; Kathy Huppler Hullsiek; Lillian Tugume; Edwin Nuwagira; Edward Mpoza; Emily E Evans; Reuben Kiggundu; Katelyn A Pastick; Kenneth Ssebambulidde; Andrew Akampurira; Darlisha A Williams; Ananta S Bangdiwala; Mahsa Abassi; Abdu K Musubire; Melanie R Nicol; Conrad Muzoora; David B Meya; David R Boulware
Journal:  Lancet Infect Dis       Date:  2019-08       Impact factor: 25.071

5.  In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.

Authors:  Lin Cong; Yong Liao; Suteng Yang; Rongya Yang
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

6.  Sertraline demonstrates fungicidal activity in vitro for Coccidioides immitis.

Authors:  Simon Paul; Roger B Mortimer; Marilyn Mitchell
Journal:  Mycology       Date:  2016-07-06

Review 7.  Immunomodulation as Therapy for Fungal Infection: Are We Closer?

Authors:  Qi Hui Sam; Wen Shan Yew; Chaminda J Seneviratne; Matthew Wook Chang; Louis Yi Ann Chai
Journal:  Front Microbiol       Date:  2018-07-25       Impact factor: 5.640

8.  Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy.

Authors:  Xingwu Jiang; Weiqiang Lu; Xiaoyang Shen; Quan Wang; Jing Lv; Mingyao Liu; Feixiong Cheng; Zhongming Zhao; Xiufeng Pang
Journal:  JCI Insight       Date:  2018-06-07

9.  Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Authors:  Joshua Rhein; Bozena M Morawski; Kathy Huppler Hullsiek; Henry W Nabeta; Reuben Kiggundu; Lillian Tugume; Abdu Musubire; Andrew Akampurira; Kyle D Smith; Ali Alhadab; Darlisha A Williams; Mahsa Abassi; Nathan C Bahr; Sruti S Velamakanni; James Fisher; Kirsten Nielsen; David B Meya; David R Boulware
Journal:  Lancet Infect Dis       Date:  2016-03-10       Impact factor: 25.071

10.  Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review.

Authors:  Fabien Bévalot; Nathalie Cartiser; Charline Bottinelli; Laurent Fanton; Jérôme Guitton
Journal:  Forensic Toxicol       Date:  2015-10-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.